Sign Up
NEWSROOM
We are data-driven and are focused on contributing to research and treatments for unmet medical needs
Recent News
Mar 24, 2025
Read More
Feb 12, 2025
Feb 10, 2025
Select News Releases
All News
24
Mar
INmune Bio Inc. to Report Fourth Quarter 2024 Financial Results and Provide Corporate Update on Marc...
12
Feb
INmune Bio Opens Phase II in High Dose Cohort of INKmune™ Trial in Prostate Cancer...
10
INmune Bio Announces Plan to Submit FDA Biologics License Application (BLA) Seeking Approval of CORD...
28
Jan
INmune Bio Inc. Expands INKmune Trial in Prostate Cancer to Veterans...
Subscribe to receive the latest updates
